HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna Pannaccione Selected Research

Carisoprodol (Soma)

11/2009NCX1 expression and functional activity increase in microglia invading the infarct core.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna Pannaccione Research Topics

Disease

9Alzheimer Disease (Alzheimer's Disease)
02/2024 - 08/2012
7Brain Ischemia (Cerebral Ischemia)
01/2019 - 01/2008
5Neurodegenerative Diseases (Neurodegenerative Disease)
05/2024 - 01/2020
5Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2019 - 11/2009
4Infarction (Infarctions)
08/2015 - 02/2008
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2024 - 12/2022
3Stroke (Strokes)
01/2019 - 01/2013
2Dementia (Dementias)
02/2024 - 12/2022
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
05/2024
1Cognitive Dysfunction
02/2024
1Neuroinflammatory Diseases
01/2022
1Insulin Resistance
01/2022
1Central Nervous System Diseases (CNS Diseases)
01/2021
1Schizophrenia (Dementia Praecox)
01/2019
1Demyelinating Diseases (Demyelinating Disease)
01/2019
1Seizures (Absence Seizure)
01/2019
1Inflammation (Inflammations)
01/2019
1Memory Disorders (Memory Loss)
01/2013
1Hypoxia (Hypoxemia)
03/2009
1Nervous System Diseases (Neurological Disorders)
04/2003

Drug/Important Bio-Agent (IBA)

5Sodium-Calcium ExchangerIBA
03/2016 - 03/2009
4Amyloid (Amyloid Fibrils)IBA
12/2023 - 01/2019
4CalciumIBA
01/2022 - 02/2013
3Protein Isoforms (Isoforms)IBA
05/2024 - 01/2013
3Oxygen (Dioxygen)IBA
01/2019 - 02/2013
3Glucose (Dextrose)FDA LinkGeneric
01/2019 - 02/2013
2beta-N-methylamino-L-alanine (beta-methylamino-L-alanine)IBA
02/2024 - 12/2022
2NeurotoxinsIBA
02/2024 - 12/2022
2Proteins (Proteins, Gene)FDA Link
12/2023 - 01/2008
2Peptides (Polypeptides)IBA
01/2022 - 08/2012
2IonsIBA
01/2021 - 02/2013
2SodiumIBA
01/2020 - 02/2013
2AntiportersIBA
01/2013 - 01/2013
2sodium-calcium exchanger 1IBA
01/2013 - 11/2009
1Transient Receptor Potential ChannelsIBA
05/2024
1Two-Pore ChannelsIBA
05/2024
1Lysergic Acid Diethylamide (LSD)IBA
05/2024
1Particulate MatterIBA
02/2024
1Glycerylphosphorylcholine (Choline Alfoscerate)IBA
02/2024
1Cholinergic Agents (Cholinergics)IBA
02/2024
1Monoterpenes (Monoterpenoids)IBA
01/2022
1PolyphenolsIBA
01/2022
1PhytochemicalsIBA
01/2022
1Volatile Oils (Essential Oils)IBA
06/2021
1Protective AgentsIBA
06/2021
1Sodium Channels (Sodium Channel)IBA
01/2021
1AcidsIBA
01/2021
1Ion Channels (Ion Channel)IBA
01/2021
1Voltage-Gated Sodium ChannelsIBA
01/2019
1ORAI1 ProteinIBA
01/2019
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2019
1D-Aspartic Acid (D Aspartate)IBA
01/2019
1Calcium-Binding ProteinsIBA
03/2016
1Calbindin 2IBA
03/2016
1Dihydrotachysterol (AT 10)IBA
08/2015
15- amino- N- butyl- 2- (4- ethoxyphenoxy)- benzamide hydrochlorideIBA
08/2015
1RE1-silencing transcription factorIBA
02/2013
1Neuroprotective AgentsIBA
01/2013
17- nitro- 5- phenyl- 1- (pyrrolidin- 1- ylmethyl)- 1H- benzo(e)(1,4)diazepin- 2(3H)- oneIBA
01/2013
1Carisoprodol (Soma)FDA LinkGeneric
11/2009
1EstersIBA
11/2009
1Fura-2 (Fura 2)IBA
11/2009
1NF-kappa B (NF-kB)IBA
03/2009
1OligodeoxyribonucleotidesIBA
02/2008
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2003

Therapy/Procedure

2Therapeutics
05/2024 - 07/2020